Homocysteine and cardiovascular disease Observational studies indicate that even moderately elevated blood concentrations of homocysteine raise the risk of cardiovascular disease (CVD), although randomized controlled trials of homocysteine-lowering therapy have generally not translated to reductions in adverse cardiovascular outcomes (26, 27)
On the other hand, desiring to seriously expand, differentiate and protect human possibilities requires going beyond concerns of precise calculation
Smoking markedly augments thrombotic risk with systemic estrogen, and maintaining routine exercise, a balanced diet, and regular blood-pressure checks may help lower cardiovascular complications
Trust these guys, they are honest
There is no quality assurance, no batch testing to pharmaceutical standards, and no clinical oversight when you are administering them on your own
The majority of these peptides currently exist in a gray zone where they are legal to purchase and own but are not approved for human use